Paxlovid Use for COVID-19 May Be Feasible in Advanced CKD
Patients with advanced chronic kidney disease (CKD) have increased risks for hospitalization and death after COVID-19 infection. Yet PaxlovidTM (nirmatrelvir…
Patients with advanced chronic kidney disease (CKD) have increased risks for hospitalization and death after COVID-19 infection. Yet PaxlovidTM (nirmatrelvir…
State-licensed pharmacists can now prescribe Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) with certain limitations to eligible patients, according to…
Good news for people with food allergies — having a food allergy cuts your risk of being infected with COVID-19…
The Food and Drug Administration (FDA)’s Vaccines and Related Biological Products Advisory Committee voted 21 to 0 (with 1 abstention)…
Post-COVID lung disease includes 3 different subtypes or subgroups that potentially require separate and different management, according to a study…
Treatment with interleukin-6 (IL-6) inhibitors decreased the risk of death among patients with COVID-19 infection by 75% compared with standard…
The risk of immediate allergic reactions or anaphylaxis after a second dose of the SARS-CoV-2 mRNA vaccine is low in…
The Food and Drug Administration (FDA) has scheduled a virtual meeting of its Vaccines and Related Biological Products Advisory Committee…
COVID-19 encourages nightmare activity, according to new research from Nature and Science of Sleep. Patients with COVID-19 have experienced increased…
The United States is in the midst of 2 epidemics, COVID-19 and obesity. “Teaching real nutrition is the strongest way…